✦ LIBER ✦

Synergistic anti-tumor effects of RAD001 with MEK inhibitors in neuroendocrine tumors: A potential mechanism of therapeutic limitation of mTOR inhibitor

✍ Scribed by Shinya Iida; Yasuhiro Miki; Katsuhiko Ono; Jun-ichi Akahira; Yasuhiro Nakamura; Takashi Suzuki; Hironobu Sasano

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P52: In vivo anti-tumor effect of mTOR i

✍ A. Kida; K. Nagai; K. Kami; Y. Kawaguchi; D. Ito; K. Fujimoto; S. Uemoto; R. Doi 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 312 KB

1057 ANTI-TUMOR ACTIVITY OF THE mTOR INH

✍ Kirstein, M.M.; Boukouris, A.E.; Pothiraju, D.; Buitrago-Molina, L.E.; Marhenke, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 53 KB

359 Phase Ib and pharmacokinetic studies

✍ M. Campone; V. Levy; V. Delecroix; E. Bourbouloux; D. Bootle; C. Tanaka; N. Shan 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Tu1608 Chemical Inhibitors of the Wnt Pa

✍ Kim, Ji Tae; Li, Jing; Jang, Eun Ryoung; Napier, Dana L.; Weiss, Heidi L.; Lee, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 50 KB

66 POSTER Synergistic anti tumor effect

✍ Y. Kato; I. Yoshino; T. Maeda; R. Tsuboi 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 73 KB

35 POSTER A Phase I trial of a combinati

✍ G. Dy; G. Croghan; A. Furth; J. Reid; L. Hanson; M. Roos; A. Tan; A. Adjei 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 134 KB